Beijing Furen Ruihui Biomedical Research Institute

Beijing Furen Ruihui Biomedical Research Institute is a specialized biotechnology research and development subsidiary of Furen Pharmaceutical Group. Based in Beijing, the institute focuses on the development of high-end biopharmaceuticals, particularly in the fields of blood coagulation factors and metabolic diseases. Its lead programs include long-acting recombinant factors for the treatment of hemophilia and innovative insulin analogs for diabetes. The institute operates as the core biological drug innovation hub for its parent group, leveraging advanced protein engineering and cell culture technologies to advance its clinical pipeline.